Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The host tissues and extracellular microenvironment (ECM) represent the complex, non-cellular structural framework that surrounds cells within all tissues and organs, providing essential physical scaffolding and biochemical cues. This environment is composed of a diverse array of macromolecules, including fibrous proteins like collagen and elastin, as well as specialized glycoproteins and proteoglycans such as hyaluronic acid (Frantz et al., 2010, Journal of Cell Science). Beyond providing physical support, the microenvironment serves as a reservoir for growth factors and mediates essential biochemical and biomechanical signals that regulate cell survival, proliferation, and migration (Anderson & Simon, 2020, Current Biology). In various diseases, particularly cancer and chronic fibrosis, the microenvironment is pathologically remodeled, leading to increased tissue stiffness and the creation of physical barriers that impede the delivery of therapeutic agents. Drugs targeting this compartment, such as hyaluronidases or collagenases, aim to degrade these barriers to enhance the penetration of co-administered therapies or to disrupt the supportive niche of malignant cells (PubChem). However, therapeutic manipulation of the host environment carries significant risks, including the potential for unintended tissue damage or the promotion of metastasis by loosening the structural constraints on tumor cells (NIH/NCBI).
Enzymatic degradation of extracellular matrix components to reduce interstitial fluid pressure and improve drug delivery; inhibition of integrin-mediated cell adhesion; and modulation of matrix metalloproteinase activity.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host tissues and extracellular microenvironment (ECM) (ECM).